Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael Wegmann. (2017) Targeting cytokines in asthma therapy: could IL-37 be a solution?. Expert Review of Respiratory Medicine 11:9, pages 675-677.
Read now
Read now
Articles from other publishers (18)
Tamara T. Haque & Pamela A. Frischmeyer-Guerrerio. (2022) The Role of TGFβ and Other Cytokines in Regulating Mast Cell Functions in Allergic Inflammation. International Journal of Molecular Sciences 23:18, pages 10864.
Crossref
Crossref
Cuiping Ren, Fengchun Liu, Chen Xing, Ruyu Zhao, Xiaoxue Tang, Miao Liu, Wenda Gao & Jijia Shen. (2022) IL-37 alleviates liver granuloma caused by Schistosoma japonicum infection by inducing alternative macrophage activation. Parasites & Vectors 15:1.
Crossref
Crossref
Alexandra Schröder, Lars P. Lunding, Ulrich M. Zissler, Christina Vock, Sina Webering, Johanna C. Ehlers, Zane Orinska, Adam Chaker, Carsten B. Schmidt‐Weber, Niklas J. Lang, Herbert B. Schiller, Marcus A. Mall, Heinz Fehrenbach, Charles A. Dinarello & Michael Wegmann. (2021) IL‐37 regulates allergic inflammation by counterbalancing pro‐inflammatory IL‐1 and IL‐33. Allergy 77:3, pages 856-869.
Crossref
Crossref
Mitsuru Sada, Masato Watanabe, Toshiya Inui, Keitaro Nakamoto, Aya Hirata, Masuo Nakamura, Kojiro Honda, Takeshi Saraya, Daisuke Kurai, Hirokazu Kimura, Haruyuki Ishii & Hajime Takizawa. (2021) Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma. Immunity, Inflammation and Disease 9:2, pages 363-373.
Crossref
Crossref
Jamie A. G. Hamilton, Miyoung Y. Lee, Rae Hunter, Raira S. Ank, Jamie Y. Story, Ganesh Talekar, Talia Sisroe, Dov B. Ballak, Andrew Fedanov, Christopher C. Porter, Elan Z. Eisenmesser, Charles A. Dinarello, Sunil S. Raikar, James DeGregori & Curtis J. Henry. (2021) Interleukin‐37 improves T‐cell‐mediated immunity and chimeric antigen receptor T‐cell therapy in aged backgrounds. Aging Cell 20:2.
Crossref
Crossref
Hanifi Yildiz, Hamit Hakan Alp, Aysel Sünnetçioğlu, Selami Ekin & Buket Mermit Çilingir. (2021) Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma. Heart & Lung 50:1, pages 177-183.
Crossref
Crossref
Miranda Sin-Man Tsang, Xiaoyu Sun & Chun Kwok Wong. (2020) The Role of New IL-1 Family Members (IL-36 and IL-38) in Atopic Dermatitis, Allergic Asthma, and Allergic Rhinitis. Current Allergy and Asthma Reports 20:8.
Crossref
Crossref
Weihua Li, Fengmin Ding, Yi Zhai, Wenting Tao, Jing Bi, Hong Fan, Nina Yin & Zhigang Wang. (2020) IL-37 is protective in allergic contact dermatitis through mast cell inhibition. International Immunopharmacology 83, pages 106476.
Crossref
Crossref
Ping Meng, Zhuang‐Gui Chen, Tian‐Tuo Zhang, Zhuo‐Zheng Liang, Xiao‐Ling Zou, Hai‐Ling Yang & Hong‐Tao Li. (2019) IL‐37 alleviates house dust mite‐induced chronic allergic asthma by targeting TSLP through the NF‐κB and ERK1/2 signaling pathways. Immunology & Cell Biology 97:4, pages 403-415.
Crossref
Crossref
Huihui Chi, Dongzhou Liu, Yue Sun, Qiongyi Hu, Honglei Liu, Xiaobing Cheng, Junna Ye, Hui Shi, Yufeng Yin, Mengru Liu, Xinyao Wu, Zhuochao Zhou, Jialin Teng, Chengde Yang & Yutong Su. (2018) Interleukin-37 is increased in adult-onset Still’s disease and associated with disease activity. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Jing Zhu, Jie Dong, Lu Ji, Peiyong Jiang, Ting Fan Leung, Dehua Liu, Lai Guan Ng, Miranda Sin-Man Tsang, Delong Jiao, Christopher Wai-Kei Lam & Chun-Kwok Wong. (2018) Anti-Allergic Inflammatory Activity of Interleukin-37 Is Mediated by Novel Signaling Cascades in Human Eosinophils. Frontiers in Immunology 9.
Crossref
Crossref
Mingsheng Zhao, Yulan Li, Chun Guo, Liyang Wang, Hongxia Chu, Faliang Zhu, Yan Li, Xiaoyan Wang, Qun Wang, Wei Zhao, Yongyu Shi, WanJun Chen & Lining Zhang. (2018) IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner. Cell Death & Disease 9:6.
Crossref
Crossref
Pio Conti, Francesco Carinci, Gianfranco Lessiani, Enrico Spinas, Spyridon K. Kritas, Gianpaolo Ronconi, Alessandro Caraffa & Theoharis C. Theoharides. (2017) Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells. Immunologic Research 65:5, pages 982-986.
Crossref
Crossref
Haipeng Liu & Baoxue Ge. (2017) Interleukin-37: a new molecular target for host-directed therapy of tuberculosis. Future Microbiology 12:6, pages 465-468.
Crossref
Crossref
Ming-Hui Xu, Feng-Lai Yuan, Shu-Jing Wang, Hui-Ying Xu, Cheng-Wan Li & Xiao Tong. (2016) Association of interleukin-18 and asthma. Inflammation 40:1, pages 324-327.
Crossref
Crossref
Haipeng Liu, Ruijuan Zheng, Peng Wang, Hua Yang, Xin He, Qun Ji, Wenjuan Bai, Hao Chen, Jianxia Chen, Wenxia Peng, Siyu Liu, Zhonghua Liu & Baoxue Ge. (2017) IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation. PLOS ONE 12:1, pages e0169922.
Crossref
Crossref
Lin Lin, Jiayi Wang, Dongjuan Liu, Sai Liu, Hao Xu, Ning Ji, Min Zhou, Xin Zeng, Dunfang Zhang, Jing Li & Qianming Chen. (2016) Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma. Scientific Reports 6:1.
Crossref
Crossref
Charles A. Dinarello, Claudia Nold-Petry, Marcel Nold, Mayumi Fujita, Suzhao Li, Soohyun Kim & Philip Bufler. (2016) Suppression of innate inflammation and immunity by interleukin-37. European Journal of Immunology 46:5, pages 1067-1081.
Crossref
Crossref